From the publishers of The New England Journal of Medicine
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.
Some content may require paid access to the site. Subscribe or
purchase a seven-day site pass for the full text of
all our clinical perspectives on medical journal articles, guidelines, and news.
The drug is now in the FDA's pregnancy category X.
Decision makes EC available without prescription (but with proof of age) to women aged 15 and older.
Court ruling would lift age restrictions on over-the-counter access.
Ospemifene is an effective tissue-selective estrogen agonist/antagonist.
NEXPLANON replaces IMPLANON.
High-dose fluconazole is now in FDA category D; single-dose therapy for vaginal candidiasis remains category C.
The FDA has updated its safety communication on transvaginally placed surgical mesh.
Evital is untested and is not approved by the FDA.
Routine magnetic resonance imaging to detect silent ruptures is recommended but often is not covered by insurance.
Antibody suppresses bone turnover, thereby lowering fracture incidence; cost could be a concern.